Beam Therapeutics (BEAM) stock forecast for 2022 – 2027

Are you interested in Beam Therapeutics Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEAM stock price in 2022-2027. Is BEAM a good long term stock? When should I take profit in Beam Therapeutics stock? Buy or sell stock? Will BEAM stock price go up? What are analysts’ forecasts for BEAM stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BEAM stock returns are also predicted based on historical data.

According to our research, BEAM stock is a very good long-term investment. BEAM share price has been in a bull cycle for the past year. Beam Therapeutics Inc. stock trend is positive.

Beam Therapeutics company info

Industry Biotechnology
Address 26 Landsdowne Street, Cambridge, MA, 02139, United States
Website https://www.beamtx.com

Forecasting

52 Week High: 92.0047 USD
52 Week Low: 65.528 USD
1 Year Forecast: 92.934 USD
5 Year Forecast: 201.377 USD

Agilent Technologies info

Market Cap: 4.7B
52 Week Change: -29.239%
52 Week High: 138.52 USD
52 Week Low: 56.34 USD
Beta: 2.12577
50 Day Moving Average: 74.3
90 Day Moving Average: 78.220
200 Day Moving Average: 89.26
Resistance Level: 73.2523
Pivot Point: 69.5059
Support Level: 63.3443
Enterprise Value: 4,446,977,536
Forward P/E: -15.56
Forward EPS: -4.12
Profit Margin: 0.00%
Shares Outstanding: 68,135,800
EBITDA: -12.23
Held Percent Institutions: 78.20%
PEG Ratio (5Y): -5.37
Trailing EPS: -6.54

Beam Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Beam Therapeutics Stock Forecast for 2022

March 2022 68 71.71 5.46%
April 2022 70 72 2.86%
May 2022 72.72 76.5 5.2%
June 2022 74.25 77.77 4.74%
July 2022 77.77 79.79 2.6%
August 2022 78 79.38 1.77%
September 2022 82.82 81.34 -1.79%
October 2022 83 86.7 4.46%
November 2022 85.14 87.12 2.33%
December 2022 86.24 90.9 5.4%

Beam Therapeutics Stock Forecast for 2023

January 2023 88.11 93.84 6.5%
February 2023 91.08 94.94 4.24%
March 2023 94.94 96.96 2.13%
April 2023 94.08 96.04 2.08%
May 2023 96.04 99.99 4.11%
June 2023 99.96 104.03 4.07%
July 2023 104.04 102.96 -1.04%
August 2023 106.05 110.16 3.88%
September 2023 108.07 110.09 1.87%
October 2023 109 112 2.75%
November 2023 114.24 112.7 -1.35%
December 2023 111.72 117.16 4.87%

Beam Therapeutics Stock Forecast for 2024

January 2024 116 116.62 0.53%
February 2024 117.81 123.42 4.76%
March 2024 118.58 125.46 5.8%
April 2024 123.22 125 1.44%
May 2024 122.5 125.73 2.64%
June 2024 125.73 129 2.6%
July 2024 129 129.36 0.28%
August 2024 130.68 134 2.54%
September 2024 131.67 132.3 0.48%
October 2024 137.36 137.61 0.18%
November 2024 140.76 142.8 1.45%
December 2024 137.2 145.86 6.31%

Beam Therapeutics Stock Forecast for 2025

January 2025 141.57 146.45 3.45%
February 2025 141.12 145.53 3.13%
March 2025 146 145.04 -0.66%
April 2025 146.02 152.51 4.44%
May 2025 155.04 153 -1.32%
June 2025 156.06 153.45 -1.67%
July 2025 152.88 155.82 1.92%
August 2025 154.84 160 3.33%
September 2025 156.8 164.63 4.99%
October 2025 161.37 168.3 4.29%
November 2025 165.64 168.67 1.83%
December 2025 169.32 169 -0.19%

Beam Therapeutics Stock Forecast for 2026

January 2026 171.7 169.29 -1.4%
February 2026 171 171.27 0.16%
March 2026 171.27 179.52 4.82%
April 2026 179.52 179.78 0.14%
May 2026 176.22 178.2 1.12%
June 2026 182.58 178.36 -2.31%
July 2026 182 184 1.1%
August 2026 187.68 186 -0.9%
September 2026 187 189 1.07%
October 2026 186.2 194.82 4.63%
November 2026 190 192 1.05%
December 2026 191.07 199.92 4.63%

Beam Therapeutics Stock Forecast for 2027

January 2027 198.9 198.97 0.04%